Results 11 to 20 of about 260,092 (192)

MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis. [PDF]

open access: yesPLoS ONE, 2017
BACKGROUND:In 2013, approximately 480,000 people developed active multidrug-resistant tuberculosis (MDR-TB), while only 97,000 started MDR-TB treatment.
Emily A Kendall   +3 more
doaj   +2 more sources

MDR-TB updated data.

open access: yes, 2023
BackgroundMultidrug-resistant tuberculosis (MDR-TB) remains a public health emergency and a threat globally. Although increasing MDR-TB cases have been recently reported in Somalia, limited information is known.
Celso JosĂ© Bruno de Oliveira (11497468)   +10 more
core   +1 more source

Rifampicin resistance in new bacteriologically confirmed pulmonary tuberculosis patients in Cameroon: a cross-sectional survey

open access: yesBMC Research Notes, 2018
Objective In Cameroon, tuberculosis (TB) cases are diagnosed and treated within a nationwide network of 248 diagnostic and treatment centres. In 2016, the centers notified a total of 175 multidrug-resistant (MDR-)TB cases, most of them retreatment cases.
J. Noeske   +4 more
doaj   +1 more source

82125 Multiple epidemics of multidrug-resistant tuberculosis revealed by spatial disease mapping and whole-genome sequencing analysis in urban China

open access: yesJournal of Clinical and Translational Science, 2021
IMPACT: Our study will integrate state-of-the-art methods in pathogen genomics, epidemiology, and geospatial analysis to identify both host- and pathogen-factors driving the MDR-TB transmission and the study outcome can inform the design of targeted ...
Chongguang Yang   +6 more
doaj   +1 more source

Diagnosis and Interim Treatment Outcomes from the First Cohort of Multidrug-Resistant Tuberculosis Patients in Tanzania. [PDF]

open access: yes, 2013
Kibong'oto National Tuberculosis Hospital (KNTH), Kilimanjaro, Tanzania. Characterize the diagnostic process and interim treatment outcomes from patients treated for multidrug-resistant tuberculosis (MDR-TB) in Tanzania.
Kumburu Happiness H.   +39 more
core   +2 more sources

HUBUNGAN DUKUNGAN KELUARGA DENGAN EFIKASI DIRI PENDERITA TUBERCULOSIS MULTIDRUG RESISTANT (TB-MDR) DI POLI TB-MDR RSUD IBNU SINA GRESIK [PDF]

open access: yes, 2018
TB-MDR terjadi karena kegagalan pengobatan, putus pengobatan, atau pengobatan yang tidak benar sehingga terjadinya resistensi primer. Penelitian ini bertujuan untuk menganalisis hubungan antara dukungan keluarga dengan Efikasi Diri penderita ...
Andri, Setya Wahyudi   +2 more
core   +3 more sources

Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study

open access: yesInfectious Diseases of Poverty, 2020
Background China incurs an extremely low treatment coverage of multidrug-resistant tuberculosis (MDR-TB). This study aimed to understand the experience of MDR-TB patients on quality of health care, and the clinical impact through an up to six-year follow-
Xu-Bin Zheng   +7 more
doaj   +1 more source

Comparison of Line Probe Assay (LPA) and Mycobacterium Growth Indicator Tubes (MGIT) Assay for Second-line TB Drug Susceptibility Testing [PDF]

open access: yes, 2021
BACKGROUND: Tuberculosis (TB) infection is one of the most prominent health issues in the world, including in Indonesia. TB is evolving into multidrug-resistant tuberculosis (MDR-TB) and requiring second-line TB drugs. Mycobacterium growth indicator tube
Choerunisa, Towifah Fauziah   +4 more
core   +1 more source

Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres

open access: yesBMC Infectious Diseases, 2019
Background The increased incidence of drug-resistant TB is a major challenge for effective TB control. Limited therapeutic options and poor treatment outcomes of DR-TB may increase drug-resistance rates.
Niccolò Riccardi   +13 more
doaj   +1 more source

Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India. [PDF]

open access: yes, 2012
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB).
Varghese, B   +51 more
core   +1 more source

Home - About - Disclaimer - Privacy